ArticleCell reports. Medicine2026

Overcoming ADC resistance in advanced colorectal cancer by dual targeting of TROP2 and PERK to suppress Wnt/β-catenin signaling.

Jie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.